14
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of the new ImmuliteTurbo cTnI assay and the original Immulite cTnI assay

, &
Pages 593-601 | Published online: 08 Jul 2009

  • Apple FS. Cardiac troponin I. In: Wu AHB, editor. Cardiac markers. Totowa, New Jersey: Humana Press, 1998: 229-45.
  • Galvani M, Ottani F, Ferrini D, Ladenson JH, Destro A, Baccos D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95:2053-9.
  • Wu AH, Feng YJ, Contois JH, Azar R, Waters D. Prognostic value of cardiac troponin I in patients with chest pain [Letter]. Clin Chem 1996; 42: 651-2.
  • Wu AH, Apple FS, Gibier WB, Jesse RL, Warshaw MM, Valdes R, Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104-21.
  • Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu AH. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999; 37: 687-93.
  • Myocardial infarction redefined-a consensus statement document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000; 21: 1502-13.
  • Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999; 45: 18-20.
  • Shi Q, Ling M, Zhang X, Zhang M, Kadijevic L, Liu S, et al. Degradation of cardiac troponin I in serum complicates comparison of cardiac troponin I assays. Clin Chem 1999; 45: 1018-25.
  • Wu AH, Feng YJ, Moore R, Apple FS, McPherson PH, Buechler KF, et al Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnl Standardization. Clin Chem 1998;44: 1198-208.
  • Hafner G, Peetz D, Erbes H, Post F, Dahm M, Peivandi AA, et al. Comparison of diagnostic performance of cardiac troponin I on the IMMULITE system with other automated troponin I assays in minor myocardial damage. Scand J CHn Lab Invest 2001; 61: 227-36.
  • Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-4.
  • Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. Part I. J Clin Chem Clin Biochem 1983; 21: 709-20.
  • Click MR, Ryder KW, Jackson SA. Graphical comparisons of interferences in clinical chemistry instrumentation. Clin Chem 1986; 32: 470-5.
  • Flordal A. The plasma dilution factor: predicting how concentrations in plasma and serum are affected by blood volume variations and blood loss. J Lab Clin Med 1995; 126: 353-7.
  • Bland JM, Altaian DG. Statistical methods for assessing the agreement between two methods of clinical measurement. Lancet 1986; i: 307-10.
  • HoIlis S. Analysis of method comparison studies. Ann Clin Biochem 1996; 33: 1-4.
  • Apple F, Wu A. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001; 47: 377-9.
  • Morrow DA, Rifai N, Tanasijeviv MJ, Wybenga DR, de Lemos JA, Antman EM. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) 11B substudy. Clin Chem 2000; 46: 453-60.
  • Christenson RH, Duh SH, Newby LK, Ohman EM, CaIiIf RM, Granger CB, et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. Clin Chem 1998; 44: 494-501.
  • Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, et al. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 1999; 340: 1623-9.
  • Katrukha AG, Bereznikova AV, Filatov VL, Esakova TV, Kolosova OV, Pettersson K, et al Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998; 44: 2433-40.
  • Panteghini M. IFCC Committee on Standardization of Markers of Cardiac Damage: premises and project presentation. International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med 1998; 36: 887-93.
  • Katrukha A, Bereznikova A, Filatov V, Esakova T. Biochemical factors influencing measurement ofcardiac troponin I in serum. Clin Chem Lab Med 1999; 37: 1091-5.
  • Gerhardt W, Nordin G, Herbert AK, Linaker Burzell B, Isakson A, Gustavsso n E, et al. Troponin T and I assays show decreased concentrations in heparin plasma compared with serum: lower recoveries in early than in late phases of myocardial injury. Clin Chem 2000; 46: 817-21.
  • Stiegler H, Fischer Y, Vazquez-Jiminez JF, Graf J, Filzmaier K, Fausten B, et al Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000; 46: 1338-44.
  • Liao R, Wang CK, Cheung HC. Coupling of calcium to the interaction of troponin I with troponin C from cardiac muscle. Biochemistry 1994; 33: 12729-34.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.